Journal of Dermatology for Physician Assistants

The official journal of the Society of Dermatology Physician Assistants

#02-Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: A Post-hoc Analysis of Phase 3 Trials

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#05-Improving Patient Selection for Adjuvant Therapy: Considerations for the Role of the 31-gene Expression Profile

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#06-Demodex Mites in Patients with Non-melanoma Skin Cancer

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#07-Validation of a Handheld Elastic-scattering Spectroscopy Device on Lesions Suggestive of Melanoma

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#08-Exposure–Response Analysis Demonstrates Response to Tapinarof is Driven by Local Effects at Sites of Application

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#09-Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Improvements in Quality of Life and Clinical Efficacy in Two Pivotal Phase 3 Trials

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#10-Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#11-Efficacy of Spesolimab for Generalized Pustular Psoriasis (GPP) Flare Treatment According to GPP Area and Severity Index (GPPASI) Score at Baseline

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#12-Effects of Ruxolitinib Cream on Patient-Reported Quality of Life in Atopic Dermatitis: 52-Week Pooled Results from Two Phase 3 Studies

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

#13-High-threshold Responses to Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis

November 29th, 2022 by

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November … Read more


Notice: Undefined variable: content in /var/www/wp-content/themes/jdpa/category.php on line 66

Comments closed

Journal of Dermatology for Physician Assistants

  • Official journal of the Society of Dermatology Physician Assistants
  • Copyright 2022 Society of Dermatology Physician Assistants
  • All Rights Reserved

300 N Washington Street
Suite 407
Alexandria, VA 22314
Toll Free: 844-DERMPAS (844-337-6727)

Facebook Twitter Linkedin